Newsgroups Main » Newsgroups Directory » Science and Technology » Medicine
Hepatitis ( sci.med.diseases.hepatitis )
From ugm3aa@leeds.ac.uk Wed Jun 21 01:16:04 1995
Status: RO
Path: uunet!bounce-back
From: ugm3aa@leeds.ac.uk (Abdul W Abdul)
Newsgroups: news.announce.newgroups,news.groups,bionet.virology,sci.med,sci.med.diseases.cancer,sci.med.telemedicine,sci.med.pathology,talk.politics.medicine
Subject: RFD: sci.med.diseases.hepatitis
Followup-To: news.groups
Date: 21 Jun 1995 01:11:27 -0400
Organization: Leeds University, School of Medicine
Lines: 108
Sender: tale@uunet.uu.net
Approved: tale@uunet.uu.net
Message-ID: <3s89lv$sv5@rodan.UU.NET>
NNTP-Posting-Host: rodan.uu.net
Xref: gs2.UU.NET news.announce.newgroups:7068 news.groups:154640 bionet.virology:3598 sci.med:132684 sci.med.diseases.cancer:2982 sci.med.telemedicine:6043 sci.med.pathology:827 talk.politics.medicine:27528
REQUEST FOR DISSCUSSION (RFD)
unmoderated newsgroup sci.med.diseases.hepatitis
Newsgroups line:
sci.med.diseases.hepatitis Hepatitis diseases.
This is a formal Request for Discussion on the creation of the
unmoderated newsgroup sci.med.diseases.hepatitis. It is being issued
according to the accepted guidelines for newsgroup creation. Its
language is based on previous RFDs.
RATIONALE
==========
Hepatitis disease meaning the inflammation of the liver (hepat=liver,
itis=inflammation) is a serious disease usually caused by hepatitis
virus with millions of people infected throughout the world.
The discussion of hepatitis diseases appears regularly in other
related newsgroups such as sci.med, sci.med.diseases.cancer and
bionet.virology, with demands for more information on the disease
or even requests for help on particular issues concerning hepatitis.
There is a mailing list for hepatitis C patients, and it is increasing
daily in size. The mailing list members (more than 150) are interested
in such newsgroup, because it will be their gateway to the world for
getting more support and information. I also found many supporters for
the creation of this newsgroup, when I had posted a pre-RFD enquiry to
bionet.virology.
CHARTER
========
The proposed newsgroup would be devoted to all aspects and kinds
of hepatitis diseases. This newsgroup would be a good place where all
people who are interested in the disease (doctors and experts in this
field) can communicate with each other and share views and opinions.
Not forgetting millions of people who are infected with hepatitis,
this newsgroup would give support to those people and would be a good
place for them to interact with the experts. Let me make it clear
here that the creation of this newsgroup is not intended to
fractionate or separate hepatitis discussion in any other related
newsgroup, but is to create a new specialised discussion forum
on hepatitis diseases. So, articles regarding hepatitis cross-posted
to other related newsgroups are welcomed.
A partial list of the intended topics would be:
-All types of viral hepatitis and non viral hepatitis.
-Prognosis and symptoms of hepatitis.
-Complications of hepatitis.
-The chronic carrier state.
-Vaccination and drugs.
-Epidemiology of hepatitis.
-Books, journals, articles and newsletters related to hepatitis.
-Support for hepatitis patients.
MAILING LISTS
==============
There is a mailing list for Hepatitis C patients.
The mailing list owner is Geffrey Thorpe (geffreyt@tenet.edu).
To subscribe to this mailing list send a message to:
listserv@sjuvm.stjohns.edu
and write in the body of the message:
SUB HEPV-L yourfirstname yourlastname
Example:
SUB HEPV-L John Smith
There is a plan to establish a gateway between the mailing list
and the newsgroup.
DISTRIBUTION
============
This RFD is being cross-posted to the following relevant newsgroups :
news.announce.newgroups, news.groups,
bionet.virology, sci.med, sci.med.diseases.cancer,
sci.med.telemedicine, sci.med.pathology, talk.politics.medicine.
In addition, it will be posted to the following mailing list :
hepv-l@sjuvm.stjohns.edu
PROCEDURE
==========
Please post any responses to this message to "news.groups" newsgroup
only. All discussion about the merits of this proposal should appear
on news.groups.
FUTURE CALL FOR VOTES (CFV)
============================
After a discussion period of 21-30 days, if there are no overwhelming
objections to the proposed newsgroup there will be a Call For Votes
(CFV) posted to the same newsgroups as this RFD. The voting period
will be at least 21 days. If the newsgroup passes by receiving 100
more YES votes than NO votes, and at least twice as many YES votes
as NO votes, it will be created.
Proponent: ugm3aa@leeds.ac.uk (Abdul W Abdul)
Mentor: huuskone@cc.helsinki.fi (Taneli Huuskonen)
From warren@syra.net Mon Jul 24 18:09:03 1995
Path: uunet!in1.uu.net!bounce-back
From: warren@syra.net (Warren Lavallee)
Newsgroups: news.announce.newgroups,news.groups,bionet.virology,sci.med,sci.med.diseases.cancer,sci.med.pathology,sci.med.telemedicine,talk.politics.medicine
Subject: CFV: sci.med.diseases.hepatitis
Followup-To: poster
Date: 20 Jul 1995 22:22:06 -0000
Organization: Usenet Volunteer Votetakers
Lines: 119
Sender: tale@uunet.uu.net
Approved: tale@uunet.uu.net
Expires: 11 Aug 1995 00:00:00 GMT
Message-ID: <sci.med.diseases.hepatitis-CFV1@uunet.uu.net>
Reply-To: voting@syra.net
NNTP-Posting-Host: rodan.uu.net
Xref: uunet news.announce.newgroups:7191 news.groups:160293 bionet.virology:3910 sci.med:136237 sci.med.diseases.cancer:3442 sci.med.pathology:1027 sci.med.telemedicine:6406 talk.politics.medicine:30451
FIRST CALL FOR VOTES (of 2)
unmoderated group sci.med.diseases.hepatitis
Newsgroups line:
sci.med.diseases.hepatitis Hepatitis diseases.
Votes must be received by 23:59:59 UTC, 10 Aug 1995.
This vote is being conducted by a neutral third party. For voting
questions only contact Warren Lavallee <warren@Syra.NET>. For
questions about the proposed group contact Abdul W Abdul
<alwahabi.albanna@nildram.co.uk>.
RATIONALE
Hepatitis disease meaning the inflammation of the liver (hepat=liver,
itis=inflammation) is a serious caused usually by hepatitis virus with
millions of people infected throughout the world.
The discussion of hepatitis diseases appears regularly in other related
newsgroups such as sci.med, sci.med.diseases.cancer and bionet.virology,
with demands for more information on the disease or even requests for
help on particular issues conerning hepatitis. There is a mailing list
for hepatitis C patients, and it is increasing daily in size. The
mailing list members (more than 150) are interested in such newsgroup,
because it will be there gateway to the world for getting more support
and information.
I also found many supporters for the creation of this newsgroup, when
I had posted a pre-RFD enquiry to bionet.virology.
CHARTER
The proposed newsgroup would be devoted to all aspects and kinds of
hepatitis diseases. This newsgroup would be a good place where all
people interested in the disease (doctors and experts in this field)
can communicate with each other and share views and opinions.
Not forgetting millions of people who are infected with hepatitis,
this newsgroup would give support to those people and would be a good
place for them to interact with the experts.
Let me make it clear here that the creation of this newsgroup is
not intended to fractionate or separate hepatitis discussion in any
other related newsgroup, but is to create a new specialized discussion
forum on hepatitis diseases. So, articles regarding hepatitis
cross-posted to other related newsgroups are welcomed.
A partial list of the intended topics would be:
-All types of viral hepatitis and non viral hepatitis.
-Prognosis and symptoms of hepatitis.
-Complications of hepatitis.
-The chronic carrier state.
-Vaccines and drugs.
-Epidemiology of hepatitis.
-Books, journals, articles and newsletters related to hepatitis.
-Support for hepatitis patients.
There is a plan to establish a gateway between HEPV-L mailing list
and the newsgroup.
HOW TO VOTE
Send MAIL to: voting@Syra.NET
Just Replying should work if you are not reading this on a mailing list.
Your mail message should contain *one* and only one of the following
statements. DO NOT QUOTE THIS CFV IN YOUR VOTE.
I vote YES on sci.med.diseases.hepatitis
I vote NO on sci.med.diseases.hepatitis
I vote ABSTAIN on sci.med.diseases.hepatitis
I CANCEL my vote on sci.med.diseases.hepatitis
Neither ABSTAIN nor CANCEL messages are counted as votes; they serve
only to cancel any previous vote. Abstentions are noted in the final
vote list, whereas CANCEL removes your vote from that list entirely.
(This is the only difference between the two.)
Anything else may be rejected by the automatic vote counting program. The
votetaker will respond to your received ballots with a personal acknowledge-
ment by mail - if you do not receive one within several days, try again.
It's your responsibility to make sure your vote is registered correctly.
If you later change your mind you may vote again; only your last valid
vote will count.
Anonymous votes will not be accepted. Votes mailed by WWW/HTML/CGI
forms are considered anonymous votes. (The vote must be mailed
directly from the voter to the votetaker.)
In cases where voting fraud is determined to have occurred, it is
standard operating procedure to delete ALL votes submitted by the
violator.
If you give anyone a copy of the CFV, it must be whole and unmodified.
When in doubt, ask the votetaker.
Standard Guidelines for voting apply: no more than one vote per person,
no more than one vote per account. If you attempt multiple votes or
other vote fraud, all your votes may be canceled and your name published.
The complete vote list will be posted with the vote result, including
how each person voted. Note that Usenet votes are not done by secret
ballot.
There will then be a five-day period during which the published vote
list may be corrected and any irregularities addressed. The
requirements for group creation are 100 more YES votes than NO votes,
and 2/3 of all counted votes being YES.
DISTRBUTION
This CFV has been cross posted to:
bionet.virology
sci.med
sci.med.diseaes.cancer
sci.med.pathology
sci.med.telemedicine
talk.politics.medicine
And EMailed to:
HEPV-L mailing list (listserv@sjuvm.stjohns.edu)
From warren@syra.net Mon Jul 31 13:47:39 1995
Path: uunet!bounce-back
From: warren@syra.net (Warren Lavallee)
Newsgroups: news.announce.newgroups,news.groups,bionet.virology,sci.med,sci.med.diseases.cancer,sci.med.pathology,sci.med.telemedicine,talk.politics.medicine
Subject: 2nd CFV: sci.med.diseases.hepatitis
Followup-To: poster
Date: 31 Jul 1995 17:46:50 -0000
Organization: Usenet Volunteer Votetakers
Lines: 119
Sender: tale@uunet.uu.net
Approved: tale@uunet.uu.net
Expires: 11 Aug 1995 00:00:00 GMT
Message-ID: <sci.med.diseases.hepatitis-CFV2@uunet.uu.net>
Reply-To: voting@syra.net
NNTP-Posting-Host: rodan.uu.net
Archive-Name: sci.med.diseases.hepatitis
Xref: uunet news.announce.newgroups:7253 news.groups:162085 bionet.virology:4032 sci.med:137430 sci.med.diseases.cancer:3607 sci.med.pathology:1078 sci.med.telemedicine:6503 talk.politics.medicine:30939
LAST CALL FOR VOTES (of 2)
unmoderated group sci.med.diseases.hepatitis
Newsgroups line:
sci.med.diseases.hepatitis Hepatitis diseases.
Votes must be received by 23:59:59 UTC, 10 Aug 1995.
This vote is being conducted by a neutral third party. For voting
questions only contact Warren Lavallee <warren@Syra.NET>. For
questions about the proposed group contact Abdul W Abdul
<alwahabi.albanna@nildram.co.uk>.
RATIONALE
Hepatitis disease meaning the inflammation of the liver (hepat=liver,
itis=inflammation) is a serious caused usually by hepatitis virus with
millions of people infected throughout the world.
The discussion of hepatitis diseases appears regularly in other related
newsgroups such as sci.med, sci.med.diseases.cancer and bionet.virology,
with demands for more information on the disease or even requests for
help on particular issues conerning hepatitis. There is a mailing list
for hepatitis C patients, and it is increasing daily in size. The
mailing list members (more than 150) are interested in such newsgroup,
because it will be there gateway to the world for getting more support
and information.
I also found many supporters for the creation of this newsgroup, when
I had posted a pre-RFD enquiry to bionet.virology.
CHARTER
The proposed newsgroup would be devoted to all aspects and kinds of
hepatitis diseases. This newsgroup would be a good place where all
people interested in the disease (doctors and experts in this field)
can communicate with each other and share views and opinions.
Not forgetting millions of people who are infected with hepatitis,
this newsgroup would give support to those people and would be a good
place for them to interact with the experts.
Let me make it clear here that the creation of this newsgroup is
not intended to fractionate or separate hepatitis discussion in any
other related newsgroup, but is to create a new specialized discussion
forum on hepatitis diseases. So, articles regarding hepatitis
cross-posted to other related newsgroups are welcomed.
A partial list of the intended topics would be:
-All types of viral hepatitis and non viral hepatitis.
-Prognosis and symptoms of hepatitis.
-Complications of hepatitis.
-The chronic carrier state.
-Vaccines and drugs.
-Epidemiology of hepatitis.
-Books, journals, articles and newsletters related to hepatitis.
-Support for hepatitis patients.
There is a plan to establish a gateway between HEPV-L mailing list
and the newsgroup.
HOW TO VOTE
Send MAIL to: voting@Syra.NET
Just Replying should work if you are not reading this on a mailing list.
Your mail message should contain *one* and only one of the following
statements. DO NOT QUOTE THIS CFV IN YOUR VOTE.
I vote YES on sci.med.diseases.hepatitis
I vote NO on sci.med.diseases.hepatitis
I vote ABSTAIN on sci.med.diseases.hepatitis
I CANCEL my vote on sci.med.diseases.hepatitis
Neither ABSTAIN nor CANCEL messages are counted as votes; they serve
only to cancel any previous vote. Abstentions are noted in the final
vote list, whereas CANCEL removes your vote from that list entirely.
(This is the only difference between the two.)
Anything else may be rejected by the automatic vote counting program. The
votetaker will respond to your received ballots with a personal acknowledge-
ment by mail - if you do not receive one within several days, try again.
It's your responsibility to make sure your vote is registered correctly.
If you later change your mind you may vote again; only your last valid
vote will count.
Anonymous votes will not be accepted. Votes mailed by WWW/HTML/CGI
forms are considered anonymous votes. (The vote must be mailed
directly from the voter to the votetaker.)
In cases where voting fraud is determined to have occurred, it is
standard operating procedure to delete ALL votes submitted by the
violator.
If you give anyone a copy of the CFV, it must be whole and unmodified.
When in doubt, ask the votetaker.
Standard Guidelines for voting apply: no more than one vote per person,
no more than one vote per account. If you attempt multiple votes or
other vote fraud, all your votes may be canceled and your name published.
The complete vote list will be posted with the vote result, including
how each person voted. Note that Usenet votes are not done by secret
ballot.
There will then be a five-day period during which the published vote
list may be corrected and any irregularities addressed. The
requirements for group creation are 100 more YES votes than NO votes,
and 2/3 of all counted votes being YES.
DISTRBUTION
This CFV has been cross posted to:
bionet.virology
sci.med
sci.med.diseaes.cancer
sci.med.pathology
sci.med.telemedicine
talk.politics.medicine
And EMailed to:
HEPV-L mailing list (listserv@sjuvm.stjohns.edu)
From warren@syra.net Fri Aug 11 14:54:33 1995
Path: uunet!bounce-back
From: warren@syra.net (Warren Lavallee)
Newsgroups: news.announce.newgroups,news.groups,bionet.virology,sci.med,sci.med.diseases.cancer,sci.med.pathology,sci.med.telemedicine,talk.politics.medicine
Subject: RESULT: sci.med.diseases.hepatitis passes 148:19
Followup-To: news.groups
Date: 11 Aug 1995 18:54:26 -0000
Organization: Usenet Volunteer Votetakers
Lines: 265
Sender: tale@uunet.uu.net
Approved: tale@uunet.uu.net
Message-ID: <sci.med.diseases.hepatitis-RESULT@uunet.uu.net>
NNTP-Posting-Host: rodan.uu.net
Archive-Name: sci.med.diseases.hepatitis
Xref: uunet news.announce.newgroups:7328 news.groups:163884 bionet.virology:4148 sci.med:139080 sci.med.diseases.cancer:3939 sci.med.pathology:1170 sci.med.telemedicine:6608 talk.politics.medicine:31698
RESULT
unmoderated group sci.med.diseases.hepatitis passes 148:19
There were 148 YES votes and 19 NO votes, for a total of 167 valid votes.
There were 3 abstains and 5 invalid ballots.
For group passage, YES votes must be at least 2/3 of all valid (YES and NO)
votes. There also must be at least 100 more YES votes than NO votes.
There is a five day discussion period after these results are posted. If no
serious allegations of voting irregularities are raised, the moderator of
news.announce.newgroups will create the group shortly thereafter.
sci.med.diseases.hepatitis passed on Mon Jul 31 23:17:57 1995
Newsgroups line:
sci.med.diseases.hepatitis hepatitis diseases.
This vote was being conducted by a neutral third party. For
voting questions only contact Warren Lavallee <warren@Syra.NET>.
For questions about the proposed group contact Abdul W Abdul
<alwahabi.albanna@nildram.co.uk>.
RATIONALE
Hepatitis disease meaning the inflammation of the liver (hepat=liver,
itis=inflammation) is a serious caused usually by hepatitis virus with
millions of people infected throughout the world. The discussion of
hepatitis diseases appears regularly in other related newsgroups such as
sci.med, sci.med.diseases.cancer and bionet.virology, with demands for
more information on the disease or even requests for help on particular
issues conerning hepatitis. There is a mailing list for hepatitis C
patients, and it is increasing daily in size. The mailing list members
(more than 150) are interested in such newsgroup, because it will be
there gateway to the world for getting more support and information.
I also found many supporters for the creation of this newsgroup, when
I had posted a pre-RFD enquiry to bionet.virology.
CHARTER: sci.med.diseases.hepatitis
The proposed newsgroup would be devoted to all aspects and kinds of
hepatitis diseases. This newsgroup would be a good place where all
people interested in the disease (doctors and experts in this field)
can communicate with each other and share views and opinions.
Not forgetting millions of people who are infected with hepatitis,
this newsgroup would give support to those people and would be a good
place for them to interact with the experts.
Let me make it clear here that the creation of this newsgroup is
not intended to fractionate or separate hepatitis discussion in any
other related newsgroup, but is to create a new specialized discussion
forum on hepatitis diseases. So, articles regarding hepatitis
cross-posted to other related newsgroups are welcomed.
A partial list of the intended topics would be:
-All types of viral hepatitis and non viral hepatitis.
-Prognosis and symptoms of hepatitis.
-Complications of hepatitis.
-The chronic carrier state.
-Vaccines and drugs.
-Epidemiology of hepatitis.
-Books, journals, articles and newsletters related to hepatitis.
-Support for hepatitis patients.
There is a plan to establish a gateway between HEPV-L mailing list
and the newsgroup.
[This collection of addresses is (C)1995 by Consultix Computer Services.
Permission is strictly NOT given to use this list or any part thereof to
make a mailing list, or for mass-mailings. Any other use is fine.]
sci.med.diseases.hepatitis Final Vote Ack
Voted Yes
------------------------------------------------------------------------------
abaldwin@po-1.star.k12.ia.us
adair@scr.siemens.com Jonathan Adair
ahall@cs.uml.edu Andrew Hall
al715@yfn.ysu.edu Tina M. Wood
alwahabi.albanna@nildram.co.uk Alwahabi Albanna
AMSCEUd@UniUd.It Fabio Puglisi
an359@freenet.carleton.ca Michael M. Morbey
aquist@netcom.com April Quist
baldwin@pobox.upenn.edu Sally Baldwin
baldwin@virtu.sar.usf.edu Laird Baldwin@virtu.sar.usf.edu
barryk@guild.bc.ca Barry Kolk
bb246@scn.org Dave Morey
BCapstone@aol.com
beckw@nwrain.com
bjv@herbison.com B.J. Herbison
bnguyen@airmics.gatech.edu Binh Nguyen
BobbiFrmSF@aol.com
bridget.brooklyn@smtplink.awm.gov.au
buddy@shadow.net bud
ca11@unm.edu Ivy Smith
cadesjar@calum.csclub.uwaterloo.ca Curtis "Chewbacca" Desjardins
camilla@primenet.com Camilla Cracchiolo
Carolina@megaweb.com Carolina Smith
chicago@ix.netcom.com Chicago
chispa@planet.net
churchie@ccnet.com
claudel@netcom.com Claude V. Lucas
clstampe@mailbox.syr.edu Chris Stamper
CNews17883@aol.com
critter@netcom.com Michael Piatak
cromwell@bnr.ca david (d.c.) cromwell
cryptdog@msn.fullfeed.com
DAVENPORT%A1.MYTHOS.mrouter@horus.pds.med.umich.edu Robertson Davenport M.
deena@gate.net D
dgaw@admag.com Debra Gaw
dmiessle@castle.net David Miessler
dscher@shore.net Dave Scherman
dtrue@whitecap.psesd.wednet.edu
dw2x+@andrew.cmu.edu Duane T. Williams
dwheeler@medusa.unm.edu
eclays@mozart.inet.co.th Edward T. Clayson
ECRACCHIOLO@Cerritos.edu Edith Cracchiolo
ellen@newkla.kla.com Ellen Quach
emorelan@smtplink.dsccc.com emorelan
ENN@dart.thomsoft.COM Eric Niekrug
ernst@infpav4.kfk.de Albrecht Ernst
ew045@cleveland.Freenet.Edu Bob Hume
fishhead@winternet.com mr. fishhead
fsllw@aurora.alaska.edu Linda Williams
galt@asylum.cs.utah.edu Greg Alt
gfulton@picosof.com Gib Fulton
GregShaw@msn.com Gregory Shaw
gthorpe@infinet.com Geff Thorpe
guenzi@iris02.biocine.it Immunobiology Research Institute, Siena
hellmeri@vwl.uni-freiburg.de Ingrid Hellmer
hermit@cats.ucsc.edu
hoebakeb@irwin.vetrol.com
hop@eden.com Hop Hopingardner
hsauer@marnie.teuto.de Henning Sauer
iain@anderton.demon.co.uk Iain Pybus
ind01447@pegasus.cc.ucf.edu Elli R. Maguhn
inf@zgi.com Patrick J. O'Hara
jan.coekelberghs@ping.be
JaniceF765@aol.com
jasper@mail.mpx.com.au jasper
jbyers@primenet.com James M. Byers
jcook@Fox.NSTN.Ca Joanne Cook
jdalmand@news.doas.state.ga.us J.D. Almand
jdcoates@aa.net John Coates
jeanpierre.vanderwaeren@electrabel.be Jean-Pierre Vanderwaeren
jfwalsh@twics.com John F Walsh
jlowery@artisoft.com John Lowery
jm_taylor@w470.fccc.edu Dr. John M. Taylor
Joan.Masters@Eng.Sun.COM Joan Masters
joan@rockvax.rockefeller.edu Joan Falciano
jodih@chaos.aerojet.com hilgenberg
jon@mhcnet.att.com Jon Eiseman [88]
jonboy@io.org Jonboy
joseph@cis.ohio-state.edu Sudish Joseph
jsca@cruzio.com Pat LeCourt
kaking@u.washington.edu Kristin King
Ken.Gilbert@hcsd.hac.com
khadl@ix.netcom.com Kenneth Hadlock
lance@rahul.net Lance K. Chun
Larry12345@eworld.com
larry@SLAC.Stanford.EDU Larry
lewitt@swcp.com Martin E. Lewitt
list-votes@dream.hb.north.de Martin Schr"oder
llr2@columbia.edu Lisa L Rosenblum
loretta_jacobs@marinfo.org loretta jacobs
LREA@aol.com
M.J.Jennings@damtp.cam.ac.uk Michael Jennings
MAWGOOD@alex.eun.eg
mbrosseau@mhv.net
MCCANN@FWVA.SAIC.COM
mcd12@hermes.cam.ac.uk Dr Michael Diffin
mcook2@sun1.iusb.edu MELVA J COOK
mdegroot@inforamp.net Mark v.C. de Groot
mellovit@ugene1.abbott.com Barry Mellovitz 4MG 7-2707
michaelb@passport.ca Michael Betel
mimi@ccnet.com Mimi
mking20@xmission.com Mudplant
mmason@rad.net.id
moffie@lausd.k12.ca.us
monkeypa@dircon.co.uk Linda Palund
morse@dorsai.dorsai.org Michael Ricci
mox@vpnet.chi.il.us William Moxley
mpmNS@fcolcc.hampshire.edu Michelle Murrain
nannette@paris.CS.Berkeley.EDU Nannette Simpson
ndallen@io.org Nigel Allen
neipel@viro.med.uni-erlangen.de Frank Neipel
NIEUWENDIJK@TFDL.AGRO.NL Robert van den Nieuwendijk, tel. 08370-76750
Ollivier.Robert@hsc.fr.net Ollivier Robert
pfauquet@databank.com Pat Fauquet
pgquinn@MEDUSA.UNM.EDU
pham@rock.enet.dec.com Understanding is a joy -- Tung Pham, DTN: 225-4938,
phublou@innet.be United Initiatives
pmelo@mat.uc.pt Paulo Melo
price@jove.acs.unt.edu Price Charles
profpuk@werple.mira.net.au Len Moaven
randolph.little@att.com R.S.LITTLE
reiss@surya.uni-flensburg.de Kristina Reiss
resmort@mindspring.com Ed Douglas
RGK@prof.slh.wisc.edu Rjurik Golobjatnikov
rick@bcm.tmc.edu Richard H. Miller
rufinus@cae.wisc.edu Jeffrey Rufinus
r_owen@ee.cit.ac.nz Rhys Owen
saraa@halcyon.com Sara Amber
sbiagio@risc2.iaif.pa.cnr.it Pier L. San Biagio
schurchv@lab.busfac.calpoly.edu S. Churchvara
selene@astro.ufl.edu Gottesman
sfb@bitwise.net Stuart F. Baldwin
SHEARERI@WELLINGTON.ecnz.co.nz SHEARER, Ian
SHolland@eworld.com
shuber@moose.uvm.edu Sally A. Huber
starrin@exis.net Roy Starrin
Steve18974@aol.com
stuart@ermintrude.win-uk.net Stuart Millinship
sueking@xmission.com sueking
SuzyM007@aol.com
SybilS7472@aol.com
tim@ee.cit.ac.nz Tim Naylor
Timk39@aol.com
twells@netcom.com Tabor J. Wells
wordell@ic.nanzan-u.ac.jp Charles B. Wordell
zao7007@trex.oscs.montana.edu Lorna McCormick
zardoz@garnet.berkeley.edu
zthor@ix.netcom.com Sam Kranzthor
Voted No
------------------------------------------------------------------------------
csaamw@urc.tue.nl Michiel Wijers
DANDERSON@prl.pulmonary.ubc.ca
EVANS@zeus.ahabs.wisc.edu Peter Scott Evans
griles@virginia.edu Dave Griles
grohol@alpha.acast.nova.edu John M. Grohol
helge@norway.bbs.no HELGE HAUGLAND
hitech@primenet.com HiTech
jcmurphy@smurfland.cit.buffalo.edu Jeff Murphy
jrm@globalvillag.com John R. MacWilliamson
lon@sweng.stortek.com Lon Jones
maga@vetbio.unizh.ch Giovanni Maga
mmink@server.nybc.org Michael mink
nna@leicester.ac.uk Dr A.J. Cann
rsrodger@wam.umd.edu R S Rodgers
spaete@biomail.aviron.com Richard Spaete
stainles@bga.com Dwight Brown
TOM.CHIARIZIA@hq.doe.gov
w.schmid@proline.gun.de Wolfgang Schmid
widenius@cc.helsinki.fi Risto Widenius
Abstained
------------------------------------------------------------------------------
crouchkp@flidh101.delcoelect.com Kenneth P Crouch
huuskone@cc.helsinki.fi Taneli Huuskonen
mmt@RedBrick.COM M Mike Taksar KC6ZPS
Votes in error
------------------------------------------------------------------------------
ashechtm@inforamp.net Allen Shechtman
! No vote statement in message
asi-ltd@actcom.co.il Dorit Tavori
! No vote statement in message
lawlis@mvuts.att.com
! No vote statement in message
nobody@nowhere
! Invalid address
statewd@aol.com Statewd
! No vote statement in message
USENET FACT: Flaming
Flaming is the hostile interaction between multiple Usenet users.
NewsDemon® is a trademark of K&L Technologies, Inc.
2001 - 2012 © Copyright NewsDemon.com